Integrin ␣21-mediated adhesion of human platelets to monomeric type I collagen or to the GFOGER peptide caused a time-dependent activation of PI3K and Akt phosphorylation. This process was abrogated by pharmacologic inhibition of PI3K, but not of PI3K␥ or PI3K␣. Moreover, Akt phosphorylation was undetectable in murine platelets expressing a kinase-dead mutant of PI3K (PI3K KD ), but occurred normally in PI3K␥ KD platelets. Integrin ␣21 failed to stimulate PI3K in platelets from phospholipase C␥2 (PLC␥2)-knockout mice, and we found that intracellular Ca 2؉ linked PLC␥2 to PI3K activation. Integrin ␣21 also caused a time-dependent stimulation of the focal kinase Pyk2 downstream of PLC␥2 and intracellular Ca 2؉ . Whereas activation of Pyk2 occurred normally in PI3K KD platelets, stimulation of PI3K was strongly reduced in Pyk2-knockout mice. Neither Pyk2 nor PI3K was required for ␣21-mediated adhesion and spreading. However, activation of Rap1b and inside-out stimulation of integrin ␣IIb3 were reduced after inhibition of PI3K and were significantly impaired in Pyk2-deficient platelets. Finally, both PI3K and Pyk2 significantly contributed to thrombus formation under flow. These results demonstrate that Pyk2 regulates PI3K downstream of integrin ␣21, and document a novel role for Pyk2 and PI3K in integrin ␣21 promoted inside-out activation of integrin ␣IIb3 and thrombus formation. (Blood. 2012;119(3):847-856)
IntroductionClass I PI3Ks are key signaling enzymes that phosphorylate the inositol ring of membrane phospholipids and generate different 3-phosphoinositides, important intracellular messengers that regulate several cellular processes through the downstream activation of the protein Ser/Thr kinase Akt. 1 Circulating blood platelets express all members of the class I PI3K family, which includes the PI3K␣, PI3K, PI3K␦, and PI3K␥ isoforms. PI3K activity is essential for platelet aggregation and thrombus formation, 1,2 and therefore these enzymes are potential novel targets for antithrombotic agents. For this reason, it is essential to recognize the precise contribution of every PI3K isoform in platelet activation induced by different extracellular agonists.Pharmacologic and genetic evidence indicates that PI3K plays a predominant role in the regulation of platelet function. [3][4][5][6][7] Selective inactivation of PI3K completely prevents platelet aggregation induced by the collagen receptor glycoprotein VI (GPVI) and reduces occlusive thrombus formation. 4,5 PI3K is also implicated in the platelet response to agonists that stimulate G-protein coupled receptors (GPCRs) such as ADP or thromboxane A 2 (TxA 2 ). 3,4,8,9 Whereas PI3K␦ has been demonstrated to play a minor role in platelet activation, 10 PI3K␣ was recently proposed to be as important as PI3K in GPVI signaling. 7 Similarly, several reports have documented that, in addition to PI3K, PI3K␥ is also implicated in GPCR-mediated platelet activation. 4,9,11,12 These observations are indicative of a still poorly appreciated interplay...